Delivery Order SPE2DB24D2205-SPE2DB24FDUXH

Award Date 5/31/24
Potential Completion Date 6/3/24
Potential Value $21K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $11,207.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567269176 NITAZOXANIDE 500 MG TABLET 6S, a pharmaceutical product, with a completion date of February 14, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and does not have a set-aside designation, indicating open competition....
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of NITAZOXANIDE 500 MG TABLET 6S, a pharmaceutical product. The fixed-price delivery order, valued at $24,949.38, has a period of performance through March 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,232.08, is for the delivery of 4566627218 NITAZOXANIDE 500 MG TABLET 6S. The contract has a firm fixed price and an ultimate completion date of December 6, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of NITAZOXANIDE 500 MG TABLET 6S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $6,363.94 firm-fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 27, 2024, with a completion date of September 30, 2024. This contract is a delivery order that is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop...
This federal contract award is for the delivery of NITAZOXANIDE 500 MG TABLET 6S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 27, 2025, with a completion date of February 28, 2025. The contract has a ceiling value of $34,454.87 and is a Firm Fixed Price Delivery Order contract. The contract is not designated with a set-aside...
This federal contract award is for the delivery of NITAZOXANIDE 500 MG TABLET 6S to the Defense Logistics Agency (DLA). The $32,519.27 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 15, 2024, with a completion date of November 18, 2024. The contract is a delivery order placed against AmerisourceBergen's existing $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which provides a range of...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,041.50, is for the delivery of 4566545462 - NITAZOXANIDE 500 MG TABLET 6S and has a completion date of November 26, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,961.78 firm fixed-price delivery order is for the supply of 4,566,862,352 units of the drug Nitazoxanide 500 mg tablets. The contract has an ultimate completion date of January 8, 2025 and was awarded on January 7, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $21,903.00, is for the delivery of Nitazoxanide 500 mg tablets to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 4, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This federal contract award, valued at $39,110.85, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567118252 nitazoxanide 500 mg tablets, a pharmaceutical product, with a period of performance through February 3, 2025. This is a firm-fixed-price delivery order contract, without any set-aside designation. AmerisourceBergen holds a significant Indefinite...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FDUXH
    Delivery Order

This federal contract award, with ID SPE2DB24D2205|SPE2DB24FDUXH, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,175.00 firm fixed-price delivery order is for the supply of 4564766818 - NITAZOXANIDE 500 MG TABLET 6S. The contract has an ultimate completion date of June 3, 2024.

This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.

Generated 5/16/25, 12:35 PM